Trade Summary

5 months ago, Ecor1 Capital, LLC, serving as Dir at Aktis Oncology, Inc. (AKTS), purchased 2,222,222 shares at $18.00 per share, for a total transaction value of $39,999,996.00. Following this transaction, Ecor1 Capital, LLC now holds 347,305 shares of AKTS.

This purchase represents a 119.00% decrease in Ecor1 Capital, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, January 12, 2026 and publicly disclosed via SEC Form 4 filing on Monday, January 12, 2026 at 8:28 PM ET, meaning the disclosure happened on the same day as the trade.

Aktis Oncology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.